2012 Biotech Stock Predictions: An Interim Report Card Submitted by admin on Tue, 08/28/2012 - 11:07 Read more about 2012 Biotech Stock Predictions: An Interim Report Card Source TheStreet.com Headline 2012 Biotech Stock Predictions: An Interim Report Card News Tags Cell Therapeutics Momenta Onyx Amag Pharmaceuticals Biomarin M&A Celgene Seattle Genetics Galena Biopharma ImmunoCellular Amgen Celldex Dendreon GSK Vical Oncothyreon Biogen Idec Merck KGaA Bristol-Myers Squibb Allos Spectrum Pharmaceuticals AstraZeneca
Spectrum Pharmaceuticals and Allos Therapeutics Announce Additional Extension of Tender Offer Period for Shares of Allos Therapeutics Submitted by admin on Sat, 08/18/2012 - 15:37 Read more about Spectrum Pharmaceuticals and Allos Therapeutics Announce Additional Extension of Tender Offer Period for Shares of Allos Therapeutics Source Yahoo/BusinessWire Headline Spectrum Pharmaceuticals and Allos Therapeutics Announce Additional Extension o… News Tags Allos Spectrum Pharmaceuticals
Spectrum Pharmaceuticals and Allos Therapeutics Announce Additional Extension of Tender Offer Period for Shares of Allos Therapeutics Submitted by admin on Sat, 07/21/2012 - 11:46 Read more about Spectrum Pharmaceuticals and Allos Therapeutics Announce Additional Extension of Tender Offer Period for Shares of Allos Therapeutics Source Yahoo/BusinessWire Headline Spectrum Pharmaceuticals and Allos Therapeutics Announce Additional Extension o… News Tags Spectrum Pharmaceuticals Allos M&A
Keryx: A Lot Can Go Wrong At $2 Submitted by admin on Fri, 07/13/2012 - 12:44 Read more about Keryx: A Lot Can Go Wrong At $2 Source Seeking Alpha Headline Keryx: A Lot Can Go Wrong At $2 News Tags Keryx Valeant Pharmaceuticals Pfizer Arena Pharmaceuticals Allos Abbott Laboratories
Spectrum Pharmaceuticals and Allos Therapeutics Announce Additional Extension of Tender Offer Period for Shares of Allos Therapeutics Submitted by admin on Sat, 07/07/2012 - 11:28 Read more about Spectrum Pharmaceuticals and Allos Therapeutics Announce Additional Extension of Tender Offer Period for Shares of Allos Therapeutics Source Yahoo/BusinessWire Headline Spectrum Pharmaceuticals and Allos Therapeutics Announce Additional Extension o… News Tags Spectrum Pharmaceuticals Allos M&A
Bio-Pharma Catalyst Trades And ASCO Movers: Making The Grade Submitted by admin on Tue, 05/15/2012 - 12:12 Read more about Bio-Pharma Catalyst Trades And ASCO Movers: Making The Grade Source Seeking Alpha Headline Bio-Pharma Catalyst Trades And ASCO Movers: Making The Grade News Tags ASCO Allos Ariad Pharmaceuticals Arena Pharmaceuticals Repligen Sunesis
Second Physician Survey Supports Prescription Data: Expecting 1Q Fusilev Growth Submitted by admin on Tue, 04/17/2012 - 10:42 Read more about Second Physician Survey Supports Prescription Data: Expecting 1Q Fusilev Growth Source Seeking Alpha Headline Second Physician Survey Supports Prescription Data: Expecting 1Q Fusilev Growth News Tags Fusilev physicians Spectrum Pharmaceuticals Allos Teva Pharmaceuticals
Allos to be acquired by Spectrum Pharma for $206M Submitted by admin on Thu, 04/05/2012 - 08:42 Read more about Allos to be acquired by Spectrum Pharma for $206M Source Marketwatch Headline Allos to be acquired by Spectrum Pharma for $206M News Tags M&A Spectrum Pharmaceuticals Allos
Upcoming ASCO Meeting Could Move These Stocks Submitted by admin on Wed, 04/04/2012 - 08:45 Read more about Upcoming ASCO Meeting Could Move These Stocks Source Seeking Alpha Headline Upcoming ASCO Meeting Could Move These Stocks News Tags ASCO Allos Ariad Pharmaceuticals Arqule Array Biopharma ImmunoCellular Therapeutics Exelixis
Allos Therapeutics Inc. Fourth Quarter Earnings Sneak Peek Submitted by admin on Thu, 03/01/2012 - 12:42 Read more about Allos Therapeutics Inc. Fourth Quarter Earnings Sneak Peek Source Yahoo/Wall St Cheat Sheet Headline Allos Therapeutics Inc. Fourth Quarter Earnings Sneak Peek News Tags Allos earnings